Mr. Berdugo brings over 30 years of biotech operational, corporate & business development and financial experience. He served as CBO at gene editing pioneer Editas; Co-founder and CEO at EpiVax Oncology Inc; CFO at Immune Pharmaceuticals Inc; Managing Director and Head of Life Sciences at Tegris Advisers; Founder and Managing Partner of the Explorium Global Healthcare Fund; Director, Senior Equity Research Analyst and Life Sciences Sector Leader at Lazard, Asset Management Group. Prior to that, he served as a Director of Global Business Development within Baxter’s Biopharmaceuticals group and started his career at Abbott. He currently serves on the Board of Directors of Genome Profiling, an epigenetic cancer biomarker company. He received his B.Sc. with Honors in Biotechnology from Imperial College London, his M.Sc. in Biochemical Engineering from University College London and his M.B.A. from H.E.C. Paris.